Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial

Patient-Centered Care for Obesity: How Health Care Providers Can Treat Obesity While Actively Addressing Weight Stigma and Eating Disorder Risk

(2022) Michelle I. Cardel et al.   Journal of the Academy of Nutrition and Dietetics

Social and economic cost of eating disorders in the United States: Evidence to inform policy action

(2021) Jared Streatfeild et al.   INTERNATIONAL JOURNAL OF EATING DISORDERS

Psychotherapy and Medications for Eating Disorders: Better Together?

(2020) Deborah L. Reas et al.   CLINICAL THERAPEUTICS

Psychiatric and medical correlates of DSM-5 eating disorders in a nationally representative sample of adults in the United States

(2019) Tomoko Udo et al.   INTERNATIONAL JOURNAL OF EATING DISORDERS

Rates of Help-Seeking in US Adults With Lifetime DSM-5 Eating Disorders: Prevalence Across Diagnoses and Differences by Sex and Ethnicity/Race

(2019) Jaime A. Coffino et al.   MAYO CLINIC PROCEEDINGS

Prevalence and Correlates of DSM-5–Defined Eating Disorders in a Nationally Representative Sample of U.S. Adults

(2018) Tomoko Udo et al.   BIOLOGICAL PSYCHIATRY

Pharmacologic Treatments for Binge-Eating Disorder

(2017) Susan L. McElroy   JOURNAL OF CLINICAL PSYCHIATRY

Neurobiological features of binge eating disorder

(2015) Iris M. Balodis et al.   CNS SPECTRUMS

Naltrexone Extended-Release Plus Bupropion Extended-Release for Treatment of Obesity

(2015) Susan Z. Yanovski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials

(2015) Susan L McElroy et al.   NEUROPSYCHOPHARMACOLOGY

Efficacy and Safety of Lisdexamfetamine for Treatment of Adults With Moderate to Severe Binge-Eating Disorder

(2015) Susan L. McElroy et al.   JAMA Psychiatry

Effects on cardiovascular risk factors of weight losses limited to 5–10 %

(2015) Joshua D. Brown et al.   Translational Behavioral Medicine

The Prevalence and Correlates of Binge Eating Disorder in the World Health Organization World Mental Health Surveys

(2013) Ronald C. Kessler et al.   BIOLOGICAL PSYCHIATRY

Combination therapy with naltrexone and bupropion for obesity

(2011) Sonja K Billes et al.   EXPERT OPINION ON PHARMACOTHERAPY

Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder

(2010) James I Hudson et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Psychological Treatments of Binge Eating Disorder

(2010) G. Terence Wilson et al.   ARCHIVES OF GENERAL PSYCHIATRY

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

(2010) Frank L Greenway et al.   LANCET

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial

(2010) Thomas A. Wadden et al.   Obesity

Evaluating the Power of Food Scale in obese subjects and a general sample of individuals: development and measurement properties

(2009) J C Cappelleri et al.   INTERNATIONAL JOURNAL OF OBESITY

Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo

(2009) Frank L. Greenway et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM